August 5, 2003
Yusuke Kubota, Kyoko Takano, Camille Yamada & Yuka
Tateisi
Words should be tagged according to the Penn Treebank Manual (henceforth PTB Manual) unless stated otherwise in this document. Annotators are given files in which words are automatically tagged by a POS-tagging program. You should fix (i) segmentation (tokenization) of words and sentences and (ii) POS tags assigned to words at the same time.
POS-tagged files should contain one sentence per line. Words in a sentence should be separated by spaces. Special attention should be paid to periods, parentheses, commas and quotations.
Any inconsistent segmentations of a given word in the same abstract should be left as they are unless the inconsistency occurs around hyphens, parenthesis and commas. Inconsistencies found around hyphens, parenthesis and commas should be fixed according to the principles stated in sections 2.3 and 2.5.
"HpaII" and "Hha I" are inconsistently segmented here (one with a space and the other without one) but should be left as they are since there are no hyphens, parenthesis and commas concerned.
When you have fixed the segmentation of a given word or sentence,
put one of the following marks to indicate the fixed place for later
reference.
| unchanged
(with confidence) |
[no mark] |
|
| unchanged
(without confidence) |
(@ w1 w2 w3
@) |
If you are uncertain about your
segmentation of a given word or phrase, enclosed it with the marks "(@
and "@)" |
| cut |
# |
including cases of cutting one
sentence into two as well as one word into two |
| concatenated |
= |
The POS-tagger sometimes drops a
word due to some bugs. In that case, supplement the dropped word and
put the mark "*" after the (POS-tagged) word in question. |
| dropped
word filled |
* |
The "cut" mark should be inserted between the separated two words. The "concatenated" mark should be inserted immediately after the concatenated word.
Marks indicating places where
something has been fixed such as "#" and "=" or those indicating
uncertainty on the part of the annotator such as "@@" and "?" are
introduced for the purpose of facilitating error checking at the final
stage of POS-fixing. So, there is really no precise guideline for where
to put them and where not to put them or the order among them when more
than one marks are assigned to one word. Annotators should not be
troubled with these questions and should make decisions according to
their own judgements.
Some examples follow:
Sentence-final periods should be separated from the preceding words.
Other periods should be concatenated with the preceding words.
Note that when an acronym ending in a period (e.g. L.I.S.) occurs at the sentence-final position, the last period should also be separated from the word.
Segmentations of initials, even if they are inconsistent, should be left as they are. (E.g., "J.M . Folon" should not be fixed as "J.M.Folon"or"J . M . Folon". Likewise, "J . M . Folon" should not be fixed as "J.M . Folon" or whatever.) However, in cases like "R.and" where it is clear that the initial is mistakenly concatenated with the next word, the two words should be separated as in "R . and".
Note that periods are used for various purposes other than marking sentence boundaries, such as decimal points, part of EC numbers (e.g. EC.1.2.3.4) and part of substance names (e.g. PU.1). If you are uncertain whether or not to cut a sentence at a given period, refer to the original .txt file and keep the segmentation consistent with it.
When a sentence is incorrectly separated into two in the original .tx t file, the two sentences should be concatenated into one but the word with a period (e.g. E . in the following example) should not be concatenated with the next word in the corrected POS-tagged file.
Parentheses and commas appearing inside substance names should be concatenated with preceding and following words.
Parentheses and commas appearing inside numerical expressions or formulas should also be concatenated with preceding and following words.
Other parentheses and commas should be separated from preceding and following words. Note in particular that parentheses enclosing abbreviations of substance names should be separated from preceding and following words.
Tokens like "10(-4)/bp" should be regarded as a single expression designating a unit and hence should be segmented as a single word and tagged as NN. ("10(-4)" means 104)
The rules in this section, except the first one, are tacitly observed in the Penn Treebank corpus, although they are not explicitly stipulated in the PTB manual.
Hyphens used as dashes should be separated from preceding and following words.
Words separated at hyphens inside them (e.g. "Hughling-Jackson") should be concatenated unless the fragment with the hyphen constitutes a conjunct (e.g. "up-"in"up- and downregulation"). Some examples of conjunctions follow:
Note that there are words ending with a minus. Examples of words ending with a minus are:
"-" used in expressions indication ranges or locations in genes or used as parts of substance names should all be concatenated with preceding and following words.
Expressions of the form "Substance Name (Abbreviation)-Number" should be segmented and tagged as "Substance Name/NN (/( Abbreviation/NN )/)# -Number/CD".
When "-" follows ")" in expressions of the form "Substance1 (XXX)-and Substance2 (YYY) -XXXed", (where "XXX" and "YYY" supply some information related to Substance1 and Substance2, respectively) the hyphen between ")" and "and" should be separated from preceding and following words and should be tagged as ":".
A space appearing inside a part of a substance name enclosed by parentheses should be converted to an under bar ("_"). For example, "1-(5-Isoquinoliny l sulfonyl)-2-methylpiperazine" should be converted to "1-(5-Isoquinolinyl_sulfonyl)-2-methylpiperazine". Spaces outside parentheses should be left as they are unless they are immediately preceded or followed by a hyphen.
"cannot" should be split into "can" and "not" in accordance with the PTB Manual and should be tagged as "can/MD not/RB".
"Substance Name:Substance Name" should be segmented as a single word and tagged as NN.
Parentheses and slashes in expressions of the form "Substance1 (XXX)/Substance2 (YYY)"(where "XXX" and "YYY" supply some information related to Substance1 and Substance2, respectively) should all be separated from preceding and following words. In this case, "/" should be tagged as ":".
Parentheses and semicolons appearing as part of bibliographic information that are concatenated with preceding and following words in the original .txt file should be separated from preceding and following words.
However, expressions indicating ranges of pages should be treated as a single unit and should be tagged as CD (e.g. "399-420/CD"). This is in accordance with the rule that ranges should be segmented as a single word (section 2.5). Pointers to references like "[1]" and "(1)" appearing at the end of a sentence should be segmented and tagged like "[/ ( 1/C D ]/)".
Technical terms, Latin words and idiomatic expressions that frequently appear are automatically assigned correct tags according to the Term List. Hence, if you are uncertain whether to fix the tags of such words, you should rather leave them as they are. When you are uncertain about the tags of ordinary words, try to determine them by the following procedure:
Various symbols are inserted to the POS-tagged file for the purpose of aiding the manual POS- fixing procedure. The symbols can be classified into two broad categories: (i) those marking words whose POS tags don't have to be checked and (ii) those marking words whose tags should be determined by specific principles.
This section describes in detail what these symbols mean and what they do not mean. (Note that correct POS-fixing is impossible when you are unsure how to read such symbols. Since some of the symbols are inevitably quite confusing and misleading, even an experienced annotator should pay close attention not to misunderstand the meanings of these symbols.)
POS tags already followed by "!" (e.g. "NF-kappaB/NN!", "interleukin-1/NN!") are assigned by the POS tagger according to the Term List. Hence, you don't usually have to fix such tags. However, if you find any apparent errors with these tags, correct them and put the mark "!!" (if you are confident about your correction) or "!?" (if you are not confident). If the error in question is a simple careless mistake that can be easily fixed, report it immediately by email. Also, when you find words that should be registered in the PREPOS list but is not yet registered, report it by email. Special attention should be paid to the following cases:
POSes and comments Letters followed by a tilde `~' or a comment [...], inserted immediately after the POS tag by the script tilde.pl, calls attention to correct POS tags. Comments and signs inserted by tilde.p l are all removed by the script rmtilde.p l after the manual POS-tagging process is completed.
Some words should be assigned different POS tags in accordance with the contexts in which they appear. In such cases, a candidate alternative POS pos2 is sometimes inserted in the lower case preceded by a tilde after the original POS POS1. In other words, word/POS1.pos2 means that although word was originally tagged as POS1 by the tagger, it might as well be pos2. The correct POS tag should be determined by the annotator according to the context.
When a comment [comment] is inserted immediately after the POS tag, fix the POS according to it.
Some words are surrounded by concatenations of two asterisks (e.g. **TNFRI**/NN). As for such words, you don't have to care about whether the POS is correct or not.
Asterisks are attached to words which do not appear in ordinary dictionaries. As a result, many of them are technical terms. However, asterisks are eliminated from words which are composed of combinations of more than one elements of 1-3 (e.g. E1A, PCOS, LTalpha), because they might be NNS. Instead, the comment [NNS?] is attached to such words.2
Each POS tag should be followed by one
of
the following marks:
| unchanged |
(with confidence) | [no mark] |
| unchanged | (without confidence) | @ |
| fixed | (with confidence) | ! |
| fixed | (without confidence) | ? |
| pending | ^ |
Note that
The POS of "binding" should be determined by the following procedure. (Priority should be given to higher rules over lower ones.) If you are uncertain about your decision, put the mark "^" immediately after the POS tag as in "NN^". (If you cannot determine the POS of a given instance of "binding" uniquely, you should specify the (logically and contextually) possible alternatives by the vertical bar notation as in "NN|VBG" and put "^" after the POS tag. If you cannot even specify tags like "NN|VBG", just put "^" on the word. If you can determine the tag uniquely with confidence, "^" is not necessary.)
Acronyms and abbreviations of units which do not have plural suffixes should be tagged according to different criteria described below.
However, note that gapping is exempt from this generalization. It is a grammatical construction and hence should not be prefixed with "@@".
| Prenominal | After "be" without "by-" |
||
|---|---|---|---|
| (co)cultured | VBN | VBN | |
| (co)localized | JJ | JJ | |
| abolished | VBN | VBN | |
| accepted | VBN | VBN | |
| accumulated | VBN | VBN | |
| acetylated | VBN | VBN | |
| achieved | VBN | VBN | |
| acquired | VBN | VBN | |
| activated | VBN | VBN | |
| added | VBN | VBN | |
| administered | VBN | VBN | |
| admitted | VBN | VBN | |
| advanced | JJ | ?? | |
| affected | VBN | VBN | |
| aged | JJ | JJ | |
| altered | JJ? | VBN? | |
| amplified | VBN | VBN | |
| analysed | VBN | VBN | |
| analyzed | VBN | VBN | |
| anchored | VBN | VBN | |
| anergized | VBN | VBN | |
| anucleated | JJ | JJ | |
| applied | VBN | VBN | |
| arranged | VBN | VBN | |
| arrested | VBN | VBN | |
| ascribed | VBN | VBN | |
| assessed | VBN | VBN | |
| assigned | VBN | VBN | |
| associated | VBN | VBN | |
| assumed | VBN | VBN | |
| attenuated | VBN | VBN | |
| augmented | JJ | JJ | |
| balanced | JJ | JJ | |
| barbed | JJ | JJ | |
| believed | VBN | VBN | |
| biotinylated | VBN | VBN | |
| blocked | VBN | VBN | |
| blunted | VBN | VBN | |
| born | JJ | JJ | |
| bound | VBN | VBN | |
| butylated | VBN | VBN | |
| called | VBN | VBN | |
| capped | JJ | ?? | |
| changed | VBN | VBN | |
| characterized | VBN | VBN | |
| charged | JJ | JJ | |
| classified | VBN | VBN | |
| cloned | VBN | VBN | |
| co-transfected | VBN | VBN | |
| coexpressed | VBN | VBN | |
| coimmunoadsorbed | VBN | VBN | |
| coinfected | VBN | VBN | |
| combined | JJ | VBN | |
| commited | VBN | VBN | |
| compared | VBN | VBN | |
| compensated | VBN | VBN | |
| composed | VBN | VBN | |
| comprised | VBN | VBN | |
| computerized | VBN | VBN | |
| concluded | VBN | VBN | |
| conditioned | JJ | JJ | |
| conferred | VBN | VBN | |
| confined | VBN | VBN | |
| confirmed | VBN | VBN | |
| conserved | VBN | VBN | |
| considered | VBN | VBN | |
| consisted | VBN | VBN | |
| constructed | VBN | VBN | |
| contained | VBN | VBN | |
| continued | JJ | VBN | |
| controlled | JJ | VBN | |
| converted | VBN | VBN | |
| coordinated | VBN | VBN | |
| correlated | VBN | VBN | |
| coselected | VBN | VBN | |
| cotransfected | VBN | VBN | |
| coupled | JJ | VBN | |
| created | VBN | VBN | |
| crosslinked | VBN | VBN | |
| cultured | VBN | VBN | |
| debulked | VBN | VBN | |
| decreased | VBN | VBN | |
| defined | VBN | VBN | |
| degraded | VBN | VBN | |
| delayed | VBN | VBN | |
| deleted | JJ | VBN | |
| delimited | VBN | VBN | |
| demonstrated | VBN | VBN | |
| dephosphorylated | VBN | VBN | |
| derived | VBN | VBN | |
| described | VBN | VBN | |
| deseased | JJ | JJ | |
| designated | VBN | VBN | |
| designed | VBN | VBN | |
| detailed | JJ | VBN | |
| detected | VBN | VBN | |
| determined | VBN | VBN | |
| developed | VBN | VBN | |
| differentiated | VBN | VBN | |
| diminished | VBN | VBN | |
| directed | VBN | VBN | |
| discussed | VBN | VBN | |
| disordered | VBN | VBN | |
| displayed | VBN | VBN | |
| disrupted | VBN | VBN | |
| dissociated | VBN | VBN | |
| diverged | JJ | JJ | |
| documented | VBN | VBN | |
| downregulated | ?? | VBN | |
| duplicated | JJ | JJ | |
| effected | VBN | VBN | |
| elaborated | VBN | VBN | |
| elevated | JJ | JJ | |
| eliminated | VBN | VBN | |
| elucidated | VBN | VBN | |
| elutriated | VBN | VBN | |
| embedded | JJ | JJ | |
| employed | VBN | VBN | |
| encoded | VBN | VBN | |
| endocytosed | VBN | VBN | chemical reaction |
| endowed | JJ | JJ | |
| engineered | VBN | VBN | |
| enhanced | VBN | VBN | |
| enhanced | VBN | VBN | |
| enriched | JJ | JJ | |
| errected | JJ | H | |
| established | JJ | VBN | |
| esterified | VBN | VBN | |
| evaluated | VBN | VBN | |
| examined | VBN | VBN | |
| excised | VBN | VBN | |
| excluded | VBN | VBN | |
| exerted | VBN | VBN | |
| expanded | VBN | VBN | |
| exposed | VBN | VBN | |
| expressed | VBN | VBN | |
| extended | VBN | VBN | |
| extracted | VBN | VBN | |
| grown | JJ | VBN | |
| localized | JJ | JJ | |
| Prenominal | After "be" without "by-" |
||
| fixed | JJ | ? | |
| footprinted | VBN | VBN | |
| forced | VBN | VBN | |
| formed | VBN | VBN | |
| formylated | VBN | VBN | |
| formylated | VBN | VBN | |
| found | VBN | VBN | |
| fragmented | JJ | JJ | |
| generalized | VBN | VBN | |
| generated | VBN | VBN | |
| given | JJ | VBN | Given/IN XXX (conditional) |
| grown | JJ | VBN | |
| hypopigmented | JJ | JJ | |
| hypothesized | VBN | VBN | |
| identified | VBN | VBN | |
| immobilized | VBN | VBN | |
| immortalized | VBN | VBN | |
| immunostained | VBN | VBN | |
| impaired | JJ | JJ | |
| implicated | VBN | VBN | |
| increased | VBN | VBN | |
| incubated | VBN | VBN | |
| induced | VBN | VBN | |
| infected | JJ | VBN | |
| infected | JJ | VBN | |
| inflamed | JJ | JJ | when it modifies tissues or organs |
| inhaled | VBN | JJ | |
| inherited | VBN | VBN | |
| inhibited | VBN | VBN | |
| initiated | VBN | VBN | |
| injected | VBN | VBN | |
| inoculated | VBN | VBN | |
| integrated | VBN | VBN | |
| interconnected | JJ | JJ | |
| inverted | JJ|VBN? | VBN | |
| investigated | VBN | VBN | |
| involved | VBN | VBN | |
| isolated | VBN | VBN | |
| juxtaposed | VBN | VBN | |
| Prenominal | After "be" without "by-" |
||
| known | JJ | VBN | |
| labelled | VBN | VBN | |
| limited | JJ | JJ | |
| linked | VBN | VBN | |
| loaded | VBN | VBN | |
| localized | JJ | JJ | |
| located | JJ | JJ | |
| lowered | JJ | JJ | |
| maintained | JJ | JJ | |
| mapped | VBN | VBN | |
| marked | JJ | JJ | |
| measured | VBN | VBN | |
| mediated | VBN | VBN | |
| microdissected | VBN | VBN | |
| mixed | JJ | VBN | |
| modified | VBN | VBN | |
| modulated | VBN | VBN | |
| mutagenized | VBN | VBN | |
| mutated | VBN | VBN | |
| myristoylated | VBN | VBN | |
| named | VBN | VBN | |
| needed | VBN | VBN | |
| neutralized | VBN | VBN | |
| noted | VBN | VBN | |
| noticed | VBN | VBN | |
| nucleated | JJ | JJ | |
| observed | VBN | VBN | |
| obtained | VBN | VBN | |
| opsonized | VBN | VBN | |
| optimized | VBN | VBN | |
| overexpressed | VBN | VBN | |
| oxidized | VBN | VBN | |
| Prenominal | After "be" without "by-" |
||
| paired | JJ | JJ | |
| paralleled | JJ | JJ | |
| parasitized | VBN | VBN | |
| performed | VBN | VBN | |
| perturbed | VBN | VBN | |
| phosphorylated | VBN | VBN | |
| plated | VBN | VBN | |
| poised | VBN | VBN | |
| polarized | VBN | VBN | |
| polyadenylated | VBN | VBN | |
| polyubiqitinated | VBN | VBN | |
| potentiated | JJ | JJ | |
| predicted | VBN | VBN | |
| prepared | VBN | VBN | |
| presented | VBN | VBN | |
| preserved | JJ | JJ | |
| presumed | VBN | VBN | |
| primed | VBN | VBN | |
| processed | VBN | VBN | |
| produced | VBN | VBN | |
| programmed | VBN | VBN | |
| prolonged | JJ | JJ | |
| pronounced | JJ | JJ | |
| proposed | JJ | VBN? | |
| protected | JJ | VBN | |
| published | VBN | VBN | |
| pulsed | JJ | JJ? | |
| purified | VBN | VBN | |
| radiolabeled | VBN | VBN | |
| reactivated | VBN | VBN | |
| reared | VBN | VBN | |
| rearranged | VBN | VBN | |
| reasoned | VBN | VBN | |
| recognized | VBN | VBN | |
| reconstituted | VBN | VBN | |
| reconstructed | VBN | VBN | |
| recovered | VBN | VBN | |
| recruited | VBN | VBN | |
| reduced | VBN | VBN | |
| referred | VBN | VBN | |
| regulated | VBN | VBN | |
| related | JJ | JJ | |
| released | VBN | VBN | |
| rendered | VBN | VBN | |
| repeated | JJ | VBN | |
| replaced | VBN | VBN | |
| replicated | VBN | VBN | |
| reported | VBN | VBN | |
| required | JJ | VBN | |
| rescued | VBN | VBN | |
| resected | JJ | VBN | |
| restricted | JJ | JJ | |
| resulted | VBN | VBN | |
| retained | VBN | VBN | |
| retarded | VBN | VBN | |
| retrodiffentiated | VBN | VBN | |
| returned | VBN | VBN | |
| revealed | VBN | VBN | |
| reversed | VBN | VBN | |
| revisited | VBN | VBN | |
| ruptured | VBN | VBN | |
| saturated | JJ | JJ | |
| secreted | VBN | VBN | |
| seeded | VBN | VBN | |
| selected | VBN | VBN | |
| sensitized | VBN | VBN | |
| sequestered | VBN | VBN | |
| seroconverted | VBN | VBN | |
| shared | JJ | VBN | |
| skewed | JJ | VBN | |
| slipped | JJ | JJ | |
| sorted | VBN | VBN | |
| speckled | JJ | JJ | |
| spliced | VBN | VBN | |
| stimulated | VBN | VBN | |
| stranded | JJ | JJ | |
| stratified | ɂ | ||
| stressed | JJ | JJ | |
| studied | VBN | VBN | |
| submitted | VBN | VBN | |
| substituted | VBN | VBN | |
| subtracted | VBN | VBN | |
| suggested | VBN | VBN | |
| supercoiled | JJ | JJ | |
| suppressed | VBN | VBN | |
| surveyed | VBN | VBN | |
| sustained | JJ | JJ | |
| synchronized | VBN | VBN | |
| synthesized | VBN | VBN | |
| targeted | VBN | VBN | |
| targetted | VBN | VBN | |
| termed | VBN | VBN | |
| tested | VBN | VBN | |
| transactivated | VBN | VBN | |
| transcribed | VBN | VBN | |
| transduced | VBN | VBN | |
| transfected | VBN | VBN | |
| transferred | VBN | VBN | |
| transformed | VBN | VBN | |
| translated | VBN | VBN | |
| translocated | VBN | VBN | |
| transplanted | VBN | VBN | |
| treated | VBN | VBN | |
| truncated | VBN | VBN | |
| Prenominal | After "be" without "by-" |
||
| ubiquitinated | VBN | VBN | |
| ubiquitinylated | VBN | VBN | |
| underlined | VBN | VBN | |
| underphosphorylated | VBN | VBN | |
| undertaken | VBN | VBN | |
| used | VBN | VBN | |
| utilized | VBN | VBN | |
| washed | VBN | VBN | |
| XXXmerized | JJ | JJ | |
| B. burgdorferi | => | B./FW burgdorferi/FW | |
| Borrelia burgdorferi | => | Borrelia/FW burgdorferi/FW | |
| C. Sub. | => | C./JJ Sub./NN | |
| C. albicans | => | C./FW albicans/FW | |
| C. neoformans | => | C./FW neoformans/FW | |
| Candida albicans | => | Candida/FW albicans/FW | |
| Catalytic Subunit | => | Catalytic/JJ Subunit/NN | |
| Cryptococcus neoformans | => | Cryptococcus/FW neoformans/FW | |
| D. melanogaster | => | D./FW melanogaster/FW | |
| Drosophila melanogaster | => | Drosophila/FW melanogaster/FW | |
| E. coli | => | E./FW coli/FW | |
| Escherichia coli | => | Escherichia/FW coli/FW | |
| L. donovani | => | L./FW donovani/FW | |
| L. monocytogenes | => | L./FW monocytogenes/FW | |
| L. pneumophila | => | L./FW pneumophila/FW | |
| Legionella pneumophila | => | Legionella/FW pneumophila/FW | |
| Leishmania donovani | => | Leishmania/FW donovani/FW | |
| Listeria monocytogenes | => | Listeria/FW monocytogenes/FW | |
| P. aeruginosa | => | P./FW aeruginosa/FW | |
| P. falciparum | => | P./FW falciparum/FW | |
| Pseudomonas aeruginosa | => | Pseudomonas/FW aeruginosa/FW | |
| Plasmodium falciparum | => | Plasmodium/FW falciparum/FW | |
| S. aureus | => | S./FW aureus/FW | |
| S. cerevisiae | => | S./FW cerevisiae/FW | |
| S. oedipus | => | S./FW oedipus/FW | |
| S. typhimurium | => | S./FW typhimurium/FW | |
| Saccharomyces cerevisiae | => | Saccharomyces/FW cerevisiae/FW | |
| Saguinus oedipus | => | Saguinus/FW oedipus/FW | |
| Salmonella typhimurium | => | Salmonella/FW typhimurium/FW | |
| Staphylococcus aureus | => | Staphylococcus/FW aureus/FW | |
| T. annulata | => | T./FW annulata/FW | |
| T. pallidum | => | T./FW pallidum/FW | |
| Theileria annulata | => | Theileria/FW annulata/FW | |
| Treponema pallidum | => | Treponema/FW pallidum/FW |
| bona fide | => | bona/FW fide/FW | |
| in vitro | => | in/FW vitro/FW | |
| In vitro | => | In/FW vitro/FW | |
| in vivo | => | in/FW vivo/FW | |
| In vivo | => | In/FW vivo/FW | |
| ex vivo | => | ex/FW vivo/FW | |
| Ex vivo | => | Ex/FW vivo/FW | |
| de novo | => | de/FW novo/FW | |
| De novo | => | De/FW novo/FW | |
| in situ | => | in/FW situ/FW | |
| In situ | => | In/FW situ/FW | |
| in-situ | => | in-situ/FW | |
| In-situ | => | In-situ/FW | |
| per se | => | per/FW se/FW | |
| et al | => | et/FW al/FW | |
| et al. | => | et/FW al./FW | |
| etc | => | etc/FW | |
| etc. | => | etc./FW | |
| ie. | => | i.e./FW | |
| i.e. | => | i.e./FW | |
| i. e. | => | i./FW e./FW | |
| e.g. | => | e.g./FW | |
| e. g. | => | e./FW g./FW | |
| ca. | => | ca./FW | |
| versus. | => | vs./CC | |
| via | => | via/IN | |
| vs. | => | vs./CC | |
| per | => | per/IN |
| alpha | => | alpha/NN | |
| beta | => | beta/NN | |
| gamma | => | gamma/NN | |
| kappa | => | kappa/NN | |
| Alpha | => | Alpha/NN | |
| Beta | => | Beta/NN | |
| Gamma | => | Gamma/NN | |
| Kappa | => | Kappa/NN |
| Liuwei Dihuang Pills | => | Liuwei/FW Dihuang/FW Pills/NNS | |
| bacille Calmette-Guerin vaccine | => | bacille/FW Calmette-Guerin/FW vaccine/NN |
| anlage | => | anlage/NN | |
| foci | => | foci/NNS | |
| focus | => | focus/NN | |
| mice | => | mice/NNS | |
| nuclei | => | nuclei/NNS | |
| nucleus | => | nucleus/NN | |
| pancreas | => | pancreas/NN | |
| pancreata | => | pancreata/NNS | |
| sera | => | sera/NNS | |
| serum | => | serum/NN | |
| women | => | women/NNS |
| According to | => | According/VBG to/IN | |
| As well as | => | As/RB well/RB as/IN | |
| Due to | => | Due/JJ to/TO | |
| In general | => | In/IN general/JJ | |
| In particular | => | In/IN particular/JJ | |
| Instead of | => | Instead/RB of/IN | |
| That is, | => | That/DT is/VBZ ,/, | |
| Whereas | => | Whereas/IN | |
| a means | => | a/DT means/NN | |
| according to | => | according/VBG to/IN | |
| as well | => | as/RB well/RB | |
| as well as | => | as/RB well/RB as/IN | |
| by means of | => | by/IN means/NN of/IN | |
| due to | => | due/JJ to/TO | |
| each other | => | each/DT other/JJ | |
| in general | => | in/IN general/JJ | |
| in particular | => | in/IN particular/JJ | |
| instead of | => | instead/RB of/IN | |
| so called | => | so/RB called/VBN | |
| such as | => | such/JJ as/IN | |
| that is, | => | that/DT is/VBZ ,/, | |
| whereas | => | whereas/IN | |
| at least | => | at/IN least/JJS |
| microM | => | microM/NN | |
| fmol/10(7) | => | fmol/10(7)/NN | |
| bp | => | bp/NN |
| [ | => | [/( | |
| ] | => | ]/) | |
| +/- | => | +/-/CC | |
| + | => | +/CC | |
| - | => | -/CC | |
| > | => | >/JJR | (May be RBR, depending on context) |
| < | => | </JJR | (May be RBR, depending on context) |
| = | => | =/JJ | (May be RB, depending on context) |
| CD1+RelB+ | => | CD1+RelB+/JJ | |
| CD14(+) | => | CD14(+)/JJ | |
| CD14+ | => | CD14+/JJ | |
| CD34(+) | => | CD34(+)/JJ | |
| CD4(+) | => | CD4(+)/JJ | |
| CD4(-) | => | CD4(-)/JJ | |
| CD4+ | => | CD4+/JJ | |
| CD4- | => | CD4-/JJ | |
| CD68(+) | => | CD68(+)/JJ | |
| CD68(-) | => | CD68(-)/JJ | |
| CD68+ | => | CD68+/JJ | |
| CD68- | => | CD68-/JJ | |
| CD8(+) | => | CD8(+)/JJ | |
| CD8(-) | => | CD8(-)/JJ | |
| CD8+ | => | CD8+/JJ | |
| CD8- | => | CD8-/JJ | |
| FCS+ | => | FCS+/JJ | |
| FCS- | => | FCS-/JJ | |
| GD3+ | => | GD3+/JJ | |
| GD3- | => | GD3-/JJ | |
| HTLV-I(+) | => | HTLV-I(+)/JJ | |
| p53-/- | => | p53-/-/JJ |
| (AOP)-RANTES-triggered | => | (AOP)-RANTES-triggered/JJ | |
| 3' | => | 3'/JJ | |
| 3-hydroxy-3-methylglutaryl | => | 3-hydroxy-3-methylglutaryl/JJ | |
| 5' | => | 5'/JJ | |
| 5-Isoquinolinyl | => | 5-Isoquinolinyl/JJ | |
| A-independent | => | A-independent/JJ | |
| B-lymphoblastoid | => | B-lymphoblastoid/JJ | |
| Ca(2+)-dependent | => | Ca(2+)-dependent/JJ | |
| FCS | => | FCS/JJ | |
| Human | => | Human/JJ | |
| Molecular | => | Molecular/JJ | |
| PKC-dependent | => | PKC-dependent/JJ | |
| Stat1-dependent | => | Stat1-dependent/JJ | |
| T-lymphoblastoid | => | T-lymphoblastoid/JJ | |
| adult | => | adult/JJ | |
| anti-Ig | => | anti-Ig/JJ|NN | ♦anti- : depends on context, if prenominal it's JJ but if it's nominal head it's NN |
| bHLH | => | bHLH/JJ | ♦basic helix-loop-helix |
| basal | => | basal/JJ | |
| bovine | => | bovine/JJ | |
| chromosomal | => | chromosomal/JJ | |
| chronic | => | chronic/JJ | |
| cis | => | cis/JJ | |
| dependent | => | dependent/JJ | |
| dibutyryl | => | dibutyryl/JJ | |
| dificient | => | dificient/JJ | |
| dominant-negative | => | dominant-negative/JJ | |
| elevated | => | elevated/JJ | |
| endocrine | => | endocrine/JJ | |
| erythroid | => | erythroid/JJ | |
| granulocyte-macrophage | => | granulocyte-macrophage/JJ | |
| helix-loop-helix | => | helix-loop-helix/JJ | |
| heterozygous | => | heterozygous/JJ | |
| heterozygous | => | heterozygous/JJ | |
| homozygous | => | homozygous/JJ | |
| human | => | human/JJ | |
| immune | => | immune/JJ | |
| inflammatory | => | inflammatory/JJ | |
| kinase-dependent | => | kinase-dependent/JJ | |
| located | => | located/JJ | |
| lymphoid | => | lymphoid/JJ | |
| mature | => | mature/JJ | |
| mononuclear | => | mononuclear/JJ | |
| murine | => | murine/JJ | |
| nevoid | => | nevoid/JJ | |
| novel | => | novel/JJ | |
| novel | => | novel/JJ | |
| parental | => | parental/JJ | |
| present | => | present/JJ | |
| present | => | present/JJ | |
| related | => | related/JJ | |
| related | => | related/JJ | |
| resistant | => | resistant/JJ | |
| rheumatoid | => | rheumatoid/JJ | |
| sIgD-crosslinking | => | sIgD-crosslinking/JJ | |
| sIgM-crosslinking | => | sIgM-crosslinking/JJ | |
| semimature | => | semimature/JJ | |
| synovial | => | synovial/JJ | |
| terminal | => | terminal/JJ | |
| terminal | => | terminal/JJ | |
| tissue-specific | => | tissue-specific/JJ | |
| tolerant | => | tolerant/JJ | |
| tonsillar | => | tonsillar/JJ | |
| tonsillar | => | tonsillar/JJ | |
| trans-acting | => | trans-acting/JJ | |
| trans | => | trans/JJ | |
| transcription-independent/JJ | => | transcription-independent/JJ | |
| transient | => | transient/JJ | |
| umbilical | => | umbilical/JJ | |
| unilineage | => | unilineage/JJ | |
| zinc-finger | => | zinc-finger/JJ |
| evaginate | => | evaginate/VBP|VB |
| (AOP)-RANTES | => | (AOP)-RANTES/NN | |
| 12-myristate | => | 12-myristate/NN | |
| 13-acetate | => | 13-acetate/NN | |
| 20-Epi | => | 20-Epi/NN | |
| 20-epi | => | 20-epi/NN | |
| 25-Dihydroxyvitamin | => | 25-Dihydroxyvitamin/NN | |
| 3'-UTR | => | 3'-UTR/NN | |
| 32Dcl3 | => | 32Dcl3/NN | |
| 6TG1.1 | => | 6TG1.1/NN | |
| AIR-1 | => | AIR-1/NN | |
| Academic Press | => | Academic/NNP Press/NNP | |
| B*CaM-K | => | B*CaM-K/NN | |
| BCL-2 | => | BCL-2/NN | |
| CDR2-loop | => | CDR2-loop/NN | |
| CTLA-4 | => | CTLA-4/NN | |
| D1/CDR2-loop | => | D1/CDR2-loop/NN | |
| D1/CDR3-loop | => | D1/CDR3-loop/NN | |
| FGF-1 | => | FGF-1/NN | |
| Fli-1 | => | Fli-1/NN | |
| G-CSF | => | G-CSF/NN | |
| GSK-3beta | => | GSK-3beta/NN | |
| Glucocorticoid | => | Glucocorticoid/NN | |
| HCD57-SREI | => | HCD57-SREI/NN | ♦name of a cell line |
| HES-1 | => | HES-1/NN | |
| HL60 | => | HL60/NN | |
| HS-72 | => | HS-72/NN | |
| HT-2 | => | HT-2/NN | |
| HUVECs | => | HUVECs/NNS | |
| Hepa-1 | => | Hepa-1/NN | |
| ICAM-1 | => | ICAM-1/NN | |
| IFNs | => | IFNs/NNS | |
| IL-12R | => | IL-12R/NN | |
| IL-1beta | => | IL-1beta/NN | |
| IL-1beta | => | IL-1beta/NN | |
| IL-2R | => | IL-2R/NN | |
| IL- | => | IL-/NN | |
| JNK | => | JNK/NN | |
| LEF-1 | => | LEF-1/NN | |
| LEF-1 | => | LEF-1/NN | |
| LMP-1 | => | LMP-1/NN | |
| LP | => | LP/NN | |
| M4 | => | M4/NN | |
| MAPK | => | MAPK/NN | |
| MCP-1 | => | MCP-1/NN | |
| ML-1 | => | ML-1/NN | |
| MO7e | => | MO7e/NN | ♦name of a cell line |
| NAD(P)H:quione | => | NAD(P)H:quione/NN | |
| NF-AT- | => | NF-AT-/NN | |
| NF-ATc | => | NF-ATc/NN | |
| NF-ATc | => | NF-ATc/NN | |
| NK | => | NK/NN | |
| NSAIDs | => | NSAIDs/NNS | |
| Notch1/TAN-1 | => | Notch1/TAN-1/NN | |
| OH | => | OH/NN | |
| PGG-Glucan | => | PGG-Glucan/NN | |
| SHP-1 | => | SHP-1/NN | |
| SOCS-3 | => | SOCS-3/NN | |
| STAT-5 | => | STAT-5/NN | |
| STAT5a | => | STAT5a/NN | |
| Spi-1 | => | Spi-1/NN | |
| T | => | T/NN | |
| TNF | => | TNF/NN | |
| TNF | => | TNF/NN | |
| U-937 | => | U-937/NN | |
| UF-1 | => | UF-1/NN | |
| VCAM-1 | => | VCAM-1/NN | |
| VCAM-1 | => | VCAM-1/NN | |
| X-chromosome | => | X-chromosome/NN | |
| activin | => | activin/NN | |
| aminooxypentane | => | aminooxypentane/NN | |
| anorexia | => | anorexia/NN | |
| antigen | => | antigen/NN | |
| bcl-xL | => | bcl-xL/NN | |
| beta-catenin | => | beta-catenin/NN | |
| beta-globin | => | beta-globin/NN | |
| beta-hydroxysteroid | => | beta-hydroxysteroid/NN | |
| breast | => | breast/NN | |
| c-Myc | => | c-Myc/NN | |
| c-myc | => | c-myc/NN | |
| cytochalasin | => | cytochalasin/NN | |
| dehydrastase/dimerization | => | dehydrastase/dimerization/NN | |
| elatase | => | elatase/NN | |
| factor-1 | => | factor-1/NN | |
| fibroblast | => | fibroblast/NN | |
| fos | => | fos/NN | |
| glycosphingolipid | => | glycosphingolipid/NN | |
| hIL-5 | => | hIL-5/NN | |
| haemoglobin | => | haemoglobin/NN | |
| hybrid | => | hybrid/NN | |
| hydroxysteroid | => | hydroxysteroid/NN | |
| immunoreceptor | => | immunoreceptor/NN | |
| interleukin-10 | => | interleukin-10/NN | |
| interleukin-1 | => | interleukin-1/NN | |
| interleukin-3 | => | interleukin-3/NN | |
| interleukin | => | interleukin/NN | |
| isoforms | => | isoforms/NNS | (sometimes VBZ) |
| lipid | => | lipid/NN | |
| macrophage | => | macrophage/NN | |
| mg-1 | => | mg-1/NN | |
| mispairing | => | mispairing/NN | |
| molecule-1 | => | molecule-1/NN | |
| nucleotide | => | nucleotide/NN | |
| p21 | => | p21/NN | |
| p27 | => | p27/NN | |
| p45 | => | p45/NN | |
| p62 | => | p62/NN | |
| p70(S6)-kinase | => | p70(S6)-kinase/NN | |
| p70 | => | p70/NN | |
| pRb | => | pRb/NN | |
| phi | => | phi/NN | |
| prednisolone | => | prednisolone/NN | |
| pro-interleukin | => | pro-interleukin/NN | |
| proIL-1beta | => | proIL-1beta/NN | |
| proteasome | => | proteasome/NN | |
| purine-box/antigen | => | purine-box/antigen/NN | |
| rapamycin | => | rapamycin/NN | |
| ras | => | ras/NN | |
| s6k | => | s6k/NN | |
| s | => | s/NNS | |
| sera | => | sera/NNS | (plural of serumj |
| serine/threonine | => | serine/threonine/NN | |
| signal | => | signal/NN | |
| stimulus | => | stimulus/NN | |
| thiol/disulfide | => | thiol/disulfide/NN | |
| thrombin | => | thrombin/NN | |
| tumor | => | tumor/NN | |
| 1 alpha,25(OH)2D3 | => | 1/CD alpha,25(OH)2D3/NN | |
| 1 alpha,25-(OH)2D3 | => | 1/CD alpha,25-(OH)2D3/NN | |
| 1 alpha,25-dihydroxyvitamin D3 | => | 1/CD alpha,25-dihydroxyvitamin/NN D3/NN | |
| 1,25 dihydroxyvitamin D3 | => | 1,25/CD dihydroxyvitamin/NN D3/NN | |
| 1,25(OH)2D3 | => | 1,25(OH)2D3/NN | |
| 1,25-(OH)2D3 | => | 1,25-(OH)2D3/NN | |
| 1,25-dihydroxycholecalciferol | => | 1,25-dihydroxycholecalciferol/NN | |
| 1,25-dihydroxyvitamin D3 | => | 1,25-/CD dihydroxyvitamin/NN D3/NN | |
| 1,25-dihydroxyvitamin D3 | => | 1,25-dihydroxyvitamin/NN D3/NN | |
| 2,3,7,8-tetrachlorodibenzo-p-dioxin | => | 2,3,7,8-tetrachlorodibenzo-p-dioxin/NN | |
| 3-kinase | => | 3-kinase/NN | |
| 5'-(N-ethyl)-carboxamido adenosine | => | 5'-(N-ethyl)-carboxamido adenosine/NN | |
| 5'-flanking region | => | 5'-flanking/JJ region/NN | |
| ADP-ribose | => | ADP-ribose/NN | |
| AIDS | => | AIDS/NN | |
| AIR-1 | => | AIR-1/NN | |
| AP-1 element | => | AP-1/NN element/NN | |
| AP-1 site | => | AP-1/NN site/NN | |
| AP-1 | => | AP-1/NN | name of transcription factor |
| AP-2 | => | AP-2/NN | name of transcription factor |
| AP1 | => | AP1/NN | ♦ name of transcription factor |
| APL | => | APL/NN | ♦ leukemia |
| AT2.5 | => | AT2.5/NN | ♦cell line |
| ATF-1 | => | ATF-1/NN | |
| ATRA | => | ATRA/NN | ♦ all-trans retinoic acid |
| Ab | => | Ab/NN | ♦ antibody |
| Abs | => | Abs/NNS | ♦antinodies |
| Ah-recepter | => | Ah-recepter/NN | |
| Ah | => | Ah/NN | |
| B cell | => | B/NN cell/NN | |
| B cells | => | B/NN cells/NNS | |
| B lymphocyte | => | B/NN lymphocyte/NN | |
| B lymphocytes | => | B/NN lymphocytes/NNS | |
| B lymphoma | => | B/NN lymphoma/NN | |
| B*CaM-K | => | B*CaM-K/NN | |
| B-cell | => | B-cell/NN | |
| B-cells | => | B-cells/NNS | |
| B104 | => | B104/NN | ♦cell line |
| B95-8 | => | B95-8/NN | |
| BALB/c 3T3 | => | BALB/c/NN 3T3/NN | ♦cell line |
| BCL-6 | => | BCL-6/NN | |
| BL2 | => | BL2/NN | ♦cell line |
| BSAP | => | BSAP/NN | |
| BW5147 | => | BW5147/NN | ♦cell line |
| BZLF1 promoter | => | BZLF1/NN promoter/NN | |
| BZLF1 | => | BZLF1/NN | |
| Bcl-2 | => | Bcl-2/NN | |
| CAT gene | => | CAT/NN gene/NN | |
| CD14 | => | CD14/NN | |
| CD40 | => | CD40/NN | |
| CD4 | => | CD4/NN | |
| CD8 | => | CD8/NN | |
| CSF-1 | => | CSF-1/NN | |
| Ca(2+)-ATPase | => | Ca(2+)-ATPase/NN | |
| Ca(2+)-ionophore | => | Ca(2+)-ionophore/NN | |
| Ca2+ | => | Ca2+/NN | |
| Cp | => | Cp/NN | |
| CsA | => | CsA/NN | |
| DM | => | DM/NN | |
| DN | => | DN/JJ | ♦doninant-negative |
| DNA binding | => | DNA/NN binding/NN | |
| DNA sequences | => | DNA/NN sequences/NNS | |
| DNA | DNA/NN | ||
| DNase-I | => | DNase-I/NN | |
| E(gre) | => | E(gre)/NN | |
| E1A | => | E1A/NN | |
| E2F-1 | => | E2F-1/NN | |
| E2F | => | E2F/NN | |
| EBNA-2 | => | EBNA-2/NN | |
| EBNA2 | => | EBNA2/NN | |
| EBV | => | EBV/NN | ♦Epstein-Barr Virus |
| EGR-1 | => | EGR-1/NN | |
| ER | => | ER/NN | |
| Egr-1 | => | Egr-1/NN | |
| Elf-1 | => | Elf-1/NN | |
| Epstein-Barr virus | => | Epstein-Barr/JJ virus/NN | ♦Epstein, Barr : person |
| FDC | => | FDC/NN | |
| FK506 | => | FK506/NN | |
| Fos | => | Fos/NN | |
| G(Anh)MTetra | => | G(Anh)MTetra/NN | |
| GATA-1 gene | => | GATA-1/NN gene/NN | |
| GATA-1 | => | GATA-1/NN | |
| GC box | => | GC/NN box/NN | |
| GCR | => | GCR/NN | |
| GD3 | => | GD3/NN | |
| GM-CSF gene | => | GM-CSF/NN gene/NN | |
| GM-CSF | => | GM-CSF/NN | |
| GP+E-86 | => | GP+E-86/NN | ♦cell line |
| GR mRNA | => | GR/NN mRNA/NN | |
| GR | => | GR/NN | |
| H2O2 | => | H2O2/NN | |
| HB24 | => | HB24/NN | |
| HCD57-SREI | => | HCD57-SREI/NN | |
| HES-1 | => | HES-1 | |
| HIV enhancer | => | HIV/NN enhancer/NN | |
| HIV long terminal repeat | => | HIV/NN long/JJ terminal/JJ repeat/NN | |
| HIV-1 LTR | => | HIV-1/NN LTR/NN | |
| HIV-1 LTR | => | HIV-1/NN LTR/NN | ♦human immunodeficiency virus long term repeat |
| HIV-1 | => | HIV-1/NN | ♦human immunodeficiency virus I |
| HIV-TF1 | => | HIV-TF1/NN | |
| HIV | => | HIV/NN | ♦human immunodeficiency virus |
| HL-60 | => | HL-60/NN | ♦cell line |
| HLA-DR and -DP | => | HLA-DR/NN and/CC -DP/NN | |
| HLA-DRA and DQB | => | HLA-DRA/NN and/CC DQB/NN | |
| HPB.ALL | => | HPB.ALL/NN | ♦cell line |
| HTLV-I | => | HTLV-I/NN | ♦human T-cell leukemia virus |
| HUT78 | => | HUT78/NN | ♦cell line |
| HeLa | => | HeLa/NN | ♦cell line |
| Hepa-1 | => | Hepa-1/NN | |
| I epsilon exon | => | I/NN epsilon/NN exon/NN | |
| I kappa B alpha | => | I/NN kappa/NN B/NN alpha/NN | |
| I kappa B-alpha | => | I/NN kappa/NN B-alpha/NN | |
| I kappa B | => | I/NN kappa/NN B/NN | |
| ICAM-1 | => | ICAM-1/NN | |
| ICAM-1 | => | ICAM-1/NN | |
| IFN alpha | => | IFN/NN alpha/NN | |
| IFN-MCP | => | IFN-MCP/NN | |
| IFN-alpha | => | IFN-alpha/NN | |
| IFN-gamma | => | IFN-gamma/NN | |
| IL-1 beta | => | IL-1/NN beta/NN | ♦interleukin |
| IL-10 | => | IL-10/NN | ♦interleukin |
| IL-12 | => | IL-12/NN | ♦interleukin |
| IL-13R | => | IL-13R/NN | |
| IL-1 | => | IL-1/NN | |
| IL-2 gene | => | IL-2/NN gene/NN | |
| IL-2 gene | => | IL-2/NN gene/NN | |
| IL-2 promoter | => | IL-2/NN promoter/NN | |
| IL-2 promoter | => | IL-2/NN promoter/NN | ♦interleukin |
| IL-2 | => | IL-2/NN | ♦interleukin |
| IL-2R alpha | => | IL-2R/NN alpha/NN | ♦interleukin |
| IL-2R | => | IL-2R/NN | |
| IL-3 | => | IL-3/NN | |
| IL-4 gene | => | IL-4/NN gene/NN | |
| IL-4 | => | IL-4/NN | ♦interleukin |
| IL-4R | => | IL-4R/NN | |
| IL-5 | => | IL-5/NN | |
| IL-5 | => | IL-5/NN | |
| IL-5 | => | IL-5/NN | ♦interleukin |
| IL-6 gene | => | IL-6/NN gene/NN | |
| IL-6 | => | IL-6/NN | ♦interleukin |
| IL-8 | => | IL-8/NN | ♦interleukin |
| IRF-1 | => | IRF-1/NN | |
| Id3 | => | Id3/NN | |
| Ig heavy chain mu E1 site | => | Ig/NN heavy/JJ chain/NN mu/NN E1/NN site/NN | |
| IgD | => | IgD/NN | |
| IgE | => | IgE/NN | |
| IgH | => | IgH/NN | |
| IgM | => | IgM/NN | |
| J.Jhan | => | J.Jhan/NN | ♦cell line |
| JAK3 | => | JAK3/NN | |
| JNKs | => | JNKs/NNS | |
| Jun | => | Jun/NN | |
| JunD | => | JunD/NN | |
| Jurkat | => | Jurkat/NN | ♦cell line |
| K-562 | => | K-562/NN | ♦cell line |
| K562 | => | K562/NN | ♦cell line |
| LAK | => | LAK/NN | |
| LFA-1 | => | LFA-1/NN | |
| LMP1(1-231) | => | LMP1(1-231)/NN | |
| LMP1 | => | LMP1/NN | |
| LPS | => | LPS/NN | |
| LTB4 | => | LTB4/NN | |
| LTR | => | LTR/NN | |
| LTR | => | LTR/NN | |
| LYSP100 | => | LYSP100/NN | |
| M-CSF | => | M-CSF/NN | |
| M-TAT | => | M-TAT/NN | |
| M1 | => | M1/NN | ♦cell line |
| M4 | => | M4/NN | |
| MCP-1 | => | MCP-1/NN | |
| MEL | => | MEL/NN | |
| MO7e | => | MO7e/NN | |
| MR | => | MR/NN | |
| NAC | => | NAC/NN | |
| NB4 | => | NB4/NN | ♦cell line |
| NF kappa B | => | NF/NN kappa/NN B/NN | |
| NF-AT | => | NF-AT/NN | |
| NF-ATp | => | NF-ATp/NN | |
| NF-kB | => | NF-kB/NN | |
| NF-kappa B p65 | => | NF-kappa/NN B/NN p65/NN | |
| NF-kappa B site | => | NF-kappa/NN B/NN site/NN | |
| NF-kappa B-dependent genes | => | NF-kappa/NN B-dependent/JJ genes/NNS | |
| NF-kappa B | => | NF-kappa/NN B/NN | |
| NF-kappaB | => | NF-kappaB/NN | |
| NFAT-1 | => | NFAT-1/NN | |
| NFAT1 | => | NFAT1/NN | |
| NFAT | => | NFAT/NN | |
| NFATp | => | NFATp/NN | |
| NK | => | NK/NN | |
| NS-Meg | => | NS-Meg/NN | |
| Na(+)-H(+)-antiport | => | Na(+)-H(+)-antiport/NN | |
| Na(+)-H+ antiport | => | Na(+)-H+/JJ|NN antiport/NN | |
| Nef | => | Nef/NN | |
| Northern blot | => | Northern/NN blot/NN | |
| Northern blotting | => | Northern/NN blotting/NN | |
| OBF-1 | => | OBF-1/NN | |
| OCA-B | => | OCA-B/NN | |
| OCT-1 | => | OCT-1/NN | |
| Oct-1 | => | Oct-1/NN | |
| Oct-2 | => | Oct-2/NN | |
| P3HR-1 | => | P3HR-1/NN | |
| PBL | => | PBL/NN | |
| PGE2 | => | PGE2/NN | |
| PHA | => | PHA/NN | |
| PIH | => | PIH/NN | |
| PKC-zeta | => | PKC-zeta/NN | |
| PKC | => | PKC/NN | |
| PMA | => | PMA/NN | |
| PML/RARalpha | => | PML/RARalpha/NN | |
| PML | => | PML/NN | |
| PU.1 | => | PU.1/NN | |
| R24 | => | R24/NN | |
| RA | => | RA/NN | |
| Raji | => | Raji/NN | ♦cell line |
| Rb | => | Rb/NN | |
| RelA | => | RelA/NN | |
| RelB | => | RelB/NN | |
| S phase | => | S/NN phase | |
| SK-N-Be(2) | => | SK-N-Be(2)/NN | ♦cell line |
| SLP-76 | => | SLP-76/NN | |
| SP1 binding site | => | SP1/NN binding/NN site/NN | |
| SRY | => | SRY/NN | |
| STAT1 alpha | => | STAT1/NN alpha/NN | |
| STAT3 | => | STAT3/NN | |
| STAT4 | => | STAT4/NN | |
| STAT5 | => | STAT5/NN | |
| SV40 | => | SV40/NN | |
| Southern blotting | => | Southern/NN blotting/NN | |
| Southern blot | => | Southern/NN blot/NN | |
| Southwestern blot | => | Southwestern/NN blot/NN | |
| Southwestern blotting | => | Southwestern/NN blotting/NN | |
| Sp1 site | => | Sp1/NN site/NN | |
| Sp1 | => | Sp1/NN | |
| Spi-B | => | Spi-B/NN | |
| Stat1 | => | Stat1/NN | |
| Stat3 | => | Stat3/NN | |
| SupT1 | => | SupT1/NN | ♦cell line |
| T cell activation | => | T/NN cell/NN activation/NN | |
| T cell | => | T/NN cell/NN | |
| T cells | => | T/NN cells/NNS | |
| T lymphocyte | => | T/NN lymphocyte/NN | |
| T lymphocytes | => | T/NN lymphocytes/NNS | |
| T lymphoma | => | T/NN lymphoma/NN | |
| T-cell activation | => | T-cell/NN activation/NN | |
| T-cell genes | => | T-cell/NN genes/NNS | |
| T-cell | => | T-cell/NN | |
| T-cells | => | T-cells/NNS | |
| T3 | => | T3/NN | |
| TAL-1 | => | TAL-1/NN | |
| TATA box | => | TATA/NN box/NN | |
| TCDD | => | TCDD/NN | |
| TCF-1 | => | TCF-1/NN | |
| TCR2 | => | TCR2/NN | |
| TCR | => | TCR/NN | |
| TGF-beta | => | TGF-beta/NN | |
| THP-1 | => | THP-1/NN | ♦cell line |
| THP1 | => | THP1/NN | ♦cell line |
| TNF alpha | => | TNF/NN alpha/NN | |
| TNF gene | => | TNF/NN gene/NN | |
| TNF-alpha | => | TNF-alpha/NN | |
| TNFR1 | => | TNFR1/NN | |
| TPA | => | TPA/NN | |
| TRAF3 | => | TRAF3/NN | |
| TRP | => | TRP/NN | ♦cell line |
| Tax1 | => | Tax1/NN | |
| Tax | => | Tax/NN | |
| Thymocyte | => | Thymocyte/NN | |
| Thymocytes | => | Thymocytes/NNS | |
| U937 | => | U937/NN | ♦cell line |
| UT-7 | => | UT-7/NN | ♦cell line |
| VCAM-1 | => | VCAM-1 | |
| VD | => | VD/NN | |
| VDR | => | VDR/NN | |
| VitD3 | => | VitD3/NN | |
| WEHI-3B(D+) | => | WEHI-3B(D+)/NN | ♦cell line |
| Western blot | => | Western/NN blot/NN | |
| Western blotting | => | Western/NN blotting/NN | |
| X chromosome | => | X/NN chromosome/NN | |
| X-chromosome | => | X-chromosome/NN | |
| YT-N17 | => | YT-N17/NN | ♦cell line |
| [3H]calcitriol/VDR | => | [3H]calcitriol/VDR/NN | |
| [3H]calcitriol | => | [3H]calcitriol/NN | |
| [3H]dexamethasone | => | [3H]dexamethasone/NN | |
| [3H]thymidine | => | [3H]thymidine/NN | |
| activated T cells | => | activated/VBN T/NN cells/NNS | |
| acute | => | acute/JJ | |
| adhesion molecules | => | adhesion/NN molecules/NNS | |
| aldosterone | => | aldosterone/NN | |
| alpha-methyl-1 alpha,25-(OH)2D3 | => | alpha-methyl-1/NN alpha,25-(OH)2D3/NN | |
| alpha-tcp | => | alpha-tcp/NN | |
| alpha-tosyl-L-lysine | => | alpha-tosyl-L-lysine/NN | |
| alpha-tosylphenylalanyl | => | alpha-tosylphenylalanyl/JJ | |
| androgen receptor gene | => | androgen/NN receptor/NN gene/NN | |
| apoptosis | => | apoptosis/NN | |
| atopic | => | atopic/JJ | |
| autosome | => | autosome/NN | |
| bcl-2 | => | bcl-2/NN | |
| beta-globin | => | beta-globin/NN | |
| bp | => | bp/NN | |
| breast cancer | => | breast/NN cancer/NN | |
| bronchoalveolar | => | bronchoalveolar/JJ | |
| burst-forming unit-erythroid ( BFU-E ) | => | burst-forming/JJ unit-erythroid/NN (/( BFU-E/NN )/) | |
| c-Fos | => | c-Fos/NN | |
| c-Jun | => | c-Jun/NN | |
| c-Myc | => | c-Myc/NN | |
| c-Rel | => | c-Rel/NN | |
| c-fes | => | c-fes/NN | |
| c-fos gene | => | c-fos/NN gene/NN | |
| c-fos | => | c-fos/NN | |
| c-jun | => | c-jun/NN | |
| c-kit | => | c-kit/NN | |
| c-myb | => | c-myb/NN | |
| c-myc | => | c-myc/NN | |
| cAMP | => | cAMP/NN | |
| cDNAs | => | cDNAs/NNS | |
| calcineurin | => | calcineurin/NN | |
| calcium ionophore | => | calcium/NN ionophore/NN | |
| calcium | => | calcium/NN | |
| cell lines | => | cell/NN lines/NNS | |
| cells | => | cells/NNS | |
| cellular gene | => | cellular/JJ gene/NN | |
| chromatin | => | chromatin/NN | |
| corticosteroid | => | corticosteroid/NN | |
| cortisol | => | cortisol/NN | |
| cycloheximide | => | cycloheximide/NN | |
| cyclosporin A | => | cyclosporin/NN A/NN | |
| cysteine | => | cysteine/NN | |
| cytokine genes | => | cytokine/NN genes/NNS | |
| cytokine | => | cytokine/NN | |
| cytokines | => | cytokines/NNS | |
| cytoplasm | => | cytoplasm/NN | |
| dexamethasone | => | dexamethasone/NN | |
| differentiation | => | differentiation/NN | |
| downstream sequence | => | downstream/JJ sequence/NN | |
| egr-1 | => | egr-1/NN | |
| electrophoretic mobility shift assays | => | electrophoretic/JJ mobility/NN shift/NN assays/NNS | |
| endothelial cells | => | endothelial/JJ cells/NNS | |
| enzyme | => | enzyme/NN | |
| expression | => | expression/NN | |
| factor-1 | => | factor-1/NN | |
| fluoroquinolone | => | fluoroquinolone/NN | |
| forskolin | => | forskolin/NN | |
| gamma(c) | => | gamma(c) | |
| gelatinase | => | gelatinase/NN | |
| gene expression | => | gene/NN expression/NN | |
| gene transcription | => | gene/NN transcription/NN | |
| genes | => | genes/NNS | |
| globin genes | => | globin/NN genes/NNS | |
| globin | => | globin/NN | |
| glucocorticoid receptor | => | glucocorticoid/NN receptor/NN | |
| glucocorticoid receptors | => | glucocorticoid/NN receptors/NNS | |
| glucocorticoid | => | glucocorticoid/NN | |
| glucocorticoids | => | glucocorticoids/NNS | |
| granulocyte DNA | => | granulocyte/NN DNA/NN | |
| granulocytes | => | granulocytes/NNS | |
| hGR | => | hGR/NN | |
| hIL-5 | => | hIL-5/NN | |
| hematopoietic cells | => | hematopoietic/JJ cells/NNS | |
| hemin | => | hemin/NN | |
| histone H5 | => | histone H5/NN | |
| human A gamma-globin gene | => | human/JJ A/NN gamma-globin/NN gene/NN | |
| human T cells | => | human/JJ T/NN cells/NNS | |
| human immunodeficiency virus long terminal repeat | => | human/JJ immunodeficiency/NN virus/NN long/JJ terminal/JJ repeat/NN | |
| human immunodeficiency virus type 1 enhancer | => | human/JJ immunodeficiency/NN virus/NN type/NN 1/CD enhancer/NN | |
| human immunodeficiency virus type 1 | => | human/JJ immunodeficiency/NN virus/NN type/NN 1/CD | |
| human immunodeficiency virus | => | human/JJ immunodeficiency/NN virus/NN | |
| human monocytes | => | human/JJ monocytes/NNS | |
| immediate early gene | => | immediate/JJ early/JJ gene/NN | |
| immediate-early gene | => | immediate-early/JJ gene/NN | |
| immune response | => | immune/JJ response/NN | |
| immune system | => | immune/JJ system/NN | |
| immunoglobulin genes | => | immunoglobulin/NN genes/NNS | |
| immunoglobulin | => | immunoglobulin/NN | |
| inflammatory genes | => | inflammatory/JJ genes/NNS | |
| inositol 1,4,5-trisphosphate/calcium | => | inositol/NN 1,4,5-trisphosphate/calcium/NN | |
| inositol phosphate | => | inositol phosphate/NN | |
| inositol-1,4,5-trisphosphate | => | inositol-1,4,5-trisphosphate/NN | |
| interferon | => | interferon/NN | |
| interleukin-2 enhancer | => | interleukin-2/NN enhancer/NN | |
| interleukin-2 gene | => | interleukin-2/NN gene/NN | |
| interleukin-2 | => | interleukin-2/NN | |
| interleukin-4 | => | interleukin-4/NN | |
| interleukin-5 | => | interleukin-5/NN | |
| interleukin-6 | => | interleukin-6/NN | |
| interleukin-8 | => | interleukin-8/NN | |
| islet | => | islet/NN | |
| kappa B sequence | => | kappa/NN B/NN sequence/NN | |
| leukocyte | => | leukocyte/NN | |
| lining cell | => | lining/JJ cell | |
| lining region | => | lining/JJ region | |
| lipopolysaccharide | => | lipopolysaccharide/NN | |
| long terminal repeat | => | long/JJ terminal/JJ repeat/NN | |
| lymph-node | => | lymph-node/NN | |
| lymph | => | lymph/NN | |
| lymphocyte | => | lymphocyte/NN | |
| lymphocytes | => | lymphocytes/NNS | |
| lymphokine genes | => | lymphokine/NN genes/NNS | |
| lyn | => | lyn/NN | |
| mAb | => | mAb/NN | |
| mAbs | => | mAbs/NNS | |
| mRNA | => | mRNA/NN | |
| macrophages | => | macrophages/NNS | |
| mast cell | => | mast/NN cell/NN | |
| megakaryocyte | => | megakaryocyte/NN | |
| mg-1 | => | mg-1/NN | |
| microM | => | microM/NN | |
| mineralocorticoid | => | mineralocorticoid/NN | |
| molecular | => | molecular/JJ | |
| molecule-1 | => | molecule-1/NN | |
| monocytes | => | monocytes/NNS | |
| mononuclear leukocytes | => | mononuclear/JJ leukocytes/NNS | |
| myb | => | myb/NN | |
| necrosis | => | necrosis/NN | |
| nef | => | nef/NN | |
| neutrophils | => | neutrophils/NNS | |
| nuclear extracts | => | nuclear/JJ extracts/NNS | |
| nuclear factor kappa B | => | nuclear/JJ factor/NN kappa/NN B/NN | |
| nuclear factor of activated T cells | => | nuclear/JJ factor/NN of/IN activated/VBN T/NN cells/NNS | |
| nuclear factors | => | nuclear/JJ factors/NNS | |
| nuclear translocation | => | nuclear/JJ translocation/NN | |
| nucleotide | => | nucleotide/NN | |
| octamer motif | => | octamer/NN motif/NN | |
| octamer | => | octamer/NN | |
| okadaic acid | => | okadaic/JJ acid/NN | |
| oligoadenylate synthetase | => | oligoadenylate/NN synthetase/NN | |
| oncoprotein | => | oncoprotein/NN | |
| oriP | => | oriP/NN | |
| p100 | => | p100/NN | |
| p105 | => | p105/NN | |
| p38 | => | p38/NN | |
| p50 | => | p50/NN | |
| p52 | => | p52/NN | |
| p65 | => | p65/NN | |
| patient | => | patient/NN | |
| patients | => | patients/NNS | |
| peptide | => | peptide/NN | |
| peri-kappa B | => | peri-kappa/NN B/NN | |
| peripheral blood | => | peripheral/JJ blood/NN | |
| peroxisome | => | peroxisome/NN | ♦sub-cell source |
| phagocyte | => | phagocyte/NN | |
| phorbol ester | => | phorbol/NN ester/NN | |
| phorbol esters | => | phorbol/NN esters/NNS | |
| phosphate | => | phosphate/NN | |
| phosphatidylinositol | => | phosphatidylinositol/NN | |
| phytohemagglutinin | => | phytohemagglutinin/NN | |
| plaque | => | plaque/NN | |
| plasma cortisol | => | plasma/NN cortisol/NN | |
| platelet-activating factor | => | platelet-activating/JJ factor/NN | |
| pp56(lck) | => | pp56(lck)/NN | |
| poly(ADP-ribose) polymerase | => | poly(ADP-ribose)/JJ polymerase/NN | |
| prednisolone | => | prednisolone/NN | |
| prodigiosin | => | prodigiosin/NN | |
| proliferation | => | proliferation/NN | |
| promoter | => | promoter/NN | |
| promoter | => | promoter/NN | |
| promoters | => | promoters/NNS | |
| promoters | => | promoters/NNS | |
| protein kinase C | => | protein/NN kinase/NN C/NN | |
| protein-protein | => | protein-protein/JJ | |
| proto-oncogenes | => | proto-oncogenes/NNS | |
| protooncogene c-fos | => | protooncogene/NN c-fos/NN | |
| rapamycin | => | rapamycin/NN | |
| receptors | => | receptors/NNS | |
| sIgD | => | sIgD/NN | |
| sIgM | => | sIgM/NN | |
| signaling pathway | => | signaling/NN pathway/NN | |
| signaling pathways | => | signaling/NN pathways/NNS | |
| signaling receptor | => | signaling/NN receptor | |
| signalling pathway | => | signalling/NN pathway/NN | |
| signalling pathways | => | signalling/NN pathways/NNS | |
| sn-1,2 dioctanoyl glycerol | => | sn-1,2/NN dioctanoyl/JJ glycerol/NN | |
| steroid | => | steroid/NN | |
| substrates | => | substrates/NNS | |
| tal-1 | => | tal-1/NN | |
| therapy | => | therapy/NN | |
| thrombin | => | thrombin/NN | |
| thymocyte | => | thymocyte/NN | |
| thymocytes | => | thymocytes/NNS | |
| transcription factor | => | transcription/NN factor/NN | |
| transcription factors | => | transcription/NN factors/NNS | |
| transcription | => | transcription/NN | |
| transcriptional activation | => | transcriptional/JJ activation/NN | |
| transgenic mice | => | transgenic/JJ mice/NNS | |
| tumor necrosis factor alpha | => | tumor/NN necrosis/NN factor/NN alpha/NN | |
| tumor | => | tumor/NN | |
| tumour | => | tumour/NN | |
| tyrosine kinase | => | tyrosine/NN kinase/NN | |
| tyrosine phosphorylation | => | tyrosine/NN phosphorylation/NN | |
| tyrosine | => | tyrosine/NN | |
| upstream sequence | => | upstream/JJ sequence/NN | |
| v-abl | => | v-abl/NN | |
| v-abl | => | v-abl/NN | |
| vitamin | => | vitamin/NN |
| UI - | => | UI/LS -/: | |
| TI - | => | TI/LS -/: | |
| AB - | => | AB/LS -/: |